Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peritoneal Neoplasms 2Hyperthermia 2Carcinoma 2Pleural Effusion, Malignant 1Myeloproliferative Disorder, Chronic, with Eosinophilia 1Mesothelioma, Malignant 1Mesothelioma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Abdominal Neoplasms 1

Interventions

Oxaliplatin 4Trastuzumab 2Mitomycin 2Leucovorin 2Fluorouracil 2tipifarnib 1sodium thiosulfate 1nilotinib 1motexafin lutetium 1entinostat 1Paclitaxel 1Laparoscopy 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1Floxuridine 1Erlotinib Hydrochloride 1Electrocardiography 1Drug Therapy 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 1Cetuximab 1Capecitabine 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Appendiceal Neoplasms × Cytoreduction Surgical Procedures × Clear all
NCT00052962 2012-11-22

Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
30 enrolled 10 charts
Gastrointestinal

Hyperthermia, Appendiceal Neoplasms, Carcinoma, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡